drugset / Trial / NCT06480123
Stem Cell Derived Exome for Treatment of Diabetic Foot
NaSingle-groupOpen-labelTreatment
Summary
This trial is designed to investigate the safety and efficacy of patients with diabetic foot by using stem cell derived exome.
Timeline
- Start
- 2024-08-01
- Primary completion
- 2028-12-30
- Completion
- 2033-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Stem Cell Derived Exome | Unknown | — | — |
Indications
No indication recorded.